{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:03:32Z","timestamp":1781147012979,"version":"3.54.1"},"reference-count":61,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lipidology"],"published-print":{"date-parts":[[2013,10,1]]},"DOI":"10.2217\/clp.13.59","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T10:19:48Z","timestamp":1379672388000},"page":"551-560","source":"Crossref","is-referenced-by-count":9,"title":["Setting the course for apoAII: a port in sight?"],"prefix":"10.1080","volume":"8","author":[{"given":"Henry J","family":"Pownall","sequence":"first","affiliation":[{"name":"Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiba K","family":"Gillard","sequence":"additional","affiliation":[{"name":"Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Antonio M","family":"Gotto","sequence":"additional","affiliation":[{"name":"Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,1,18]]},"reference":[{"key":"CIT0001","unstructured":"Havel RJ, Goldstein JL, Brown MS. Lipoproteins and lipid transport. In: The Metabolic Control of Disease. Bondy PK, Rosenberg LE (Eds). Saunders Publishing, PA, USA, 398\u2013494 (1980)."},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 34(4), 679\u2013697 (1966).","DOI":"10.1161\/01.CIR.34.4.679"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8(6), 737\u2013741 (1988).","DOI":"10.1161\/01.ATV.8.6.737"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Glomset JA, Parker F, Tjaden M, Williams RH. The esterification in vitro of free cholesterol in human and rat plasma. Biochim. Biophys. Acta 58, 398\u2013406 (1962).","DOI":"10.1016\/0006-3002(62)90050-1"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9(2), 155\u2013167 (1968).","DOI":"10.1016\/S0022-2275(20)43114-1"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Rosenson RS, Brewer HB Jr, Davidson WS et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125(15), 1905\u20131919 (2012).","DOI":"10.1161\/CIRCULATIONAHA.111.066589"},{"key":"CIT0007","doi-asserted-by":"crossref","unstructured":"Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J. Clin. Invest. 94(4), 1698\u20131705 (1994).","DOI":"10.1172\/JCI117515"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Fielding CJ, Shore VG, Fielding PE. A protein cofactor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46(4), 1493\u20131498 (1972).","DOI":"10.1016\/0006-291X(72)90776-0"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Anti-inflammatory properties of HDL. Circ. Res. 95(8), 764\u2013772 (2004).","DOI":"10.1161\/01.RES.0000146094.59640.13"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Yamashita J, Iwamura C, Sasaki T et al. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function. J. Immunol. 186(6), 3410\u20133420 (2011).","DOI":"10.4049\/jimmunol.1002924"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Shore B, Shore V. Heterogeneity in protein subunits of human serum high-density lipoproteins. Biochemistry 7(8), 2773\u20132777 (1968).","DOI":"10.1021\/bi00848a011"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Lux SE, John KM, Brewer HB Jr. Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains. J. Biol. Chem. 247(23), 7510\u20137518 (1972).","DOI":"10.1016\/S0021-9258(19)44555-9"},{"key":"CIT0013","doi-asserted-by":"crossref","unstructured":"Li WH, Tanimura M, Luo CC, Datta S, Chan L. The apolipoprotein multigene family: biosynthesis, structure, structure\u2013function relationships, and evolution. J. Lipid Res. 29(3), 245\u2013271 (1988).","DOI":"10.1016\/S0022-2275(20)38532-1"},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Byrne RE, Polacek D, Gordon JI, Scanu AM. The enzyme that cleaves apolipoprotein A-II upon in vitro incubation of human plasma high-density lipoprotein-3 with blood polymorphonuclear cells is an elastase. J. Biol. Chem. 259(23), 14537\u201314543 (1984).","DOI":"10.1016\/S0021-9258(17)42633-0"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Davidson WS, Silva RA. Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. Curr. Opin. Lipidol. 16(3), 295\u2013300 (2005).","DOI":"10.1097\/01.mol.0000169349.38321.ad"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Silva RA, Schneeweis LA, Krishnan SC, Zhang X, Axelsen PH, Davidson WS. The structure of apolipoprotein A-II in discoidal high density lipoproteins. J. Biol. Chem. 282(13), 9713\u20139721 (2007).","DOI":"10.1074\/jbc.M610380200"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Birjmohun RS, Dallinga-Thie GM, Kuivenhoven JA et al. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 116(18), 2029\u20132035 (2007).","DOI":"10.1161\/CIRCULATIONAHA.107.704031"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Blanco-Vaca F, Via DP, Yang CY, Massey JB, Pownall HJ. Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins. J. Lipid Res. 33(12), 1785\u20131796 (1992).","DOI":"10.1016\/S0022-2275(20)41336-7"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Weisgraber KH, Shinto LH. Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem. 266(18), 12029\u201312034 (1991).","DOI":"10.1016\/S0021-9258(18)99060-5"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J. Biol. Chem. 259(19), 12201\u201312209 (1984).","DOI":"10.1016\/S0021-9258(20)71339-6"},{"key":"CIT0021","doi-asserted-by":"crossref","unstructured":"Lund-Katz S, Murley YM, Yon E, Gillotte KL, Davidson WS. Comparison of the structural and functional effects of monomeric and dimeric human apolipoprotein A-II in high density lipoprotein particles. Lipids 31(11), 1107\u20131113 (1996).","DOI":"10.1007\/BF02524284"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Edelstein C, Halari M, Scanu AM. On the mechanism of the displacement of apolipoprotein A-I by apolipoprotein A-II from the high density lipoprotein surface. Effect of concentration and molecular forms of apolipoprotein A-II. J. Biol. Chem. 257(12), 7189\u20137195 (1982).","DOI":"10.1016\/S0021-9258(18)34555-1"},{"key":"CIT0023","doi-asserted-by":"crossref","unstructured":"Pownall HJ, Hickson D, Gotto AM Jr. Thermodynamics of lipid-protein association. The free energy of association of lecithin with reduced and carboxymethylated apolipoprotein A-II from human plasma high density lipoprotein. J. Biol. Chem. 256(19), 9849\u20139854 (1981).","DOI":"10.1016\/S0021-9258(19)68707-7"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Marzal-Casacuberta A, Blanco-Vaca F, Ishida BY et al. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J. Biol. Chem. 271(12), 6720\u20136728 (1996).","DOI":"10.1074\/jbc.271.12.6720"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Hussain MM, Zannis VI. Intracellular modification of human apolipoprotein AII (apoAII) and sites of apoAII mRNA synthesis: comparison of apoAII with apoCII and apoCIII isoproteins. Biochemistry 29(1), 209\u2013217 (1990).","DOI":"10.1021\/bi00453a029"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Bossu JP, Chartier FL, Vu-Dac N, Fruchart JC, Laine B. Transcription of the human apolipoprotein A-II is down-regulated by the first intron of its gene. Biochem. Biophys. Res. Commun. 202(2), 822\u2013829 (1994).","DOI":"10.1006\/bbrc.1994.2004"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Vu-Dac N, Schoonjans K, Kosykh V et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96(2), 741\u2013750 (1995).","DOI":"10.1172\/JCI118118"},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"Vu-Dac N, Schoonjans K, Kosykh V et al. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor. Mol. Cell Biol. 16(7), 3350\u20133360 (1996).","DOI":"10.1128\/MCB.16.7.3350"},{"key":"CIT0029","doi-asserted-by":"crossref","unstructured":"Ikewaki K, Zech LA, Kindt M, Brewer HB Jr, Rader DJ. Apolipoprotein A-II production rate is a major factor regulating the distribution of apolipoprotein A-I among HDL subclasses LpA-I and LpA-I:A-II in normolipidemic humans. Arterioscler. Thromb. Vasc. Biol. 15(3), 306\u2013312 (1995).","DOI":"10.1161\/01.ATV.15.3.306"},{"key":"CIT0030","doi-asserted-by":"crossref","unstructured":"Chisholm JW, Burleson ER, Shelness GS, Parks JS. ApoA-I secretion from HepG2 cells: evidence for the secretion of both lipid-poor apoA-I and intracellularly assembled nascent HDL. J. Lipid Res. 43(1), 36\u201344 (2002).","DOI":"10.1016\/S0022-2275(20)30184-X"},{"key":"CIT0031","doi-asserted-by":"crossref","unstructured":"Gillard BK, Lin HY, Massey JB, Pownall HJ. Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells. Biochim. Biophys. Acta 1791(12), 1125\u20131132 (2009). \u25aa Demonstrates that apoAII occurs on HDL particles that have no apoAI, and that hepatically derived factors catalyze fusion of apoAII\u2011containing particles with those containing apoAI.","DOI":"10.1016\/j.bbalip.2009.07.004"},{"key":"CIT0032","doi-asserted-by":"crossref","unstructured":"Maric J, Kiss RS, Franklin V, Marcel YL. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes. J. Biol. Chem. 280(48), 39942\u201339949 (2005).","DOI":"10.1074\/jbc.M507733200"},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Gillard BK, Chen YS, Gaubatz JW, Massey JB, Pownall HJ. Plasma factors required for human apolipoprotein A-II dimerization. Biochemistry 44(2), 471\u2013479 (2005).","DOI":"10.1021\/bi048591j"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Massey JB, Pownall HJ. Cholesterol is a determinant of the structures of discoidal high density lipoproteins formed by the solubilization of phospholipid membranes by apolipoprotein A-I. Biochim. Biophys. Acta 1781(5), 245\u2013253 (2008).","DOI":"10.1016\/j.bbalip.2008.03.003"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"Bassett GR, Gillard BK, Pownall HJ. Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes. Biochemistry 51(43), 8627\u20138635 (2012). \u25aa Demonstrates that the free cholesterol content of membranes determines the size of reconstituted HDL particles formed by microsolubilization; increased free cholesterol in membranes leads to an increase in the size of reconstituted HDL.","DOI":"10.1021\/bi3011994"},{"key":"CIT0036","doi-asserted-by":"crossref","unstructured":"Shepherd J, Packard CJ, Gotto AM Jr, Taunton OD. A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II. J. Lipid Res. 19(5), 656\u2013661 (1978).","DOI":"10.1016\/S0022-2275(20)41299-4"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"Mehta R, Gantz DL, Gursky O. Human plasma high-density lipoproteins are stabilized by kinetic factors. J. Mol. Biol. 328(1), 183\u2013192 (2003). \u25aa\u25aa Reveals, by a variety of physicochemical methods, that plasma HDL particles reside in a high\u2011energy kinetic trap from which they escape by chemical perturbations, which emulate the effects of plasma enzymes and transfer proteins.","DOI":"10.1016\/S0022-2836(03)00155-4"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Rye KA, Hime NJ, Barter PJ. Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion. J. Biol. Chem. 272(7), 3953\u20133960 (1997).","DOI":"10.1074\/jbc.272.7.3953"},{"key":"CIT0039","doi-asserted-by":"crossref","unstructured":"Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem. J. 313(Pt 1), 275\u2013282 (1996).","DOI":"10.1042\/bj3130275"},{"key":"CIT0040","doi-asserted-by":"crossref","unstructured":"Liang HQ, Rye KA, Barter PJ. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase. J. Lipid Res. 37(9), 1962\u20131970 (1996).","DOI":"10.1016\/S0022-2275(20)37561-1"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"Clay MA, Newnham HH, Barter PJ. Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. Arterioscler. Thromb. 11(2), 415\u2013422 (1991).","DOI":"10.1161\/01.ATV.11.2.415"},{"key":"CIT0042","doi-asserted-by":"crossref","unstructured":"Gillard BK, Courtney HS, Massey JB, Pownall HJ. Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption. Biochemistry 46(45), 12968\u201312978 (2007). \u25aa\u25aa Demonstrates that a bacterial protein, serum opacity factor, catalyzes the escape of HDL from a kinetic trap, thereby forming a large cholesteryl ester\u2011rich particle, a small cholesterol\u2011deficient HDL and lipid\u2011free apoAI.","DOI":"10.1021\/bi701525w"},{"key":"CIT0043","doi-asserted-by":"crossref","unstructured":"Remaley AT, Stonik JA, Demosky SJ et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys. Res. Commun. 280(3), 818\u2013823 (2001).","DOI":"10.1006\/bbrc.2000.4219"},{"key":"CIT0044","doi-asserted-by":"crossref","unstructured":"Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am. Heart J. 113(2 Pt 2), 589\u2013597 (1987).","DOI":"10.1016\/0002-8703(87)90638-7"},{"key":"CIT0045","unstructured":"Deeb SS, Takata K, Peng RL, Kajiyama G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am. J. Hum. Genet. 46(4), 822\u2013827 (1990)."},{"key":"CIT0046","doi-asserted-by":"crossref","unstructured":"Schultz JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 365(6448), 762\u2013764 (1993).","DOI":"10.1038\/365762a0"},{"key":"CIT0047","doi-asserted-by":"crossref","unstructured":"Schultz JR, Rubin EM. The properties of HDL in genetically engineered mice. Curr. Opin. Lipidol. 5(2), 126\u2013137 (1994).","DOI":"10.1097\/00041433-199404000-00009"},{"key":"CIT0048","doi-asserted-by":"crossref","unstructured":"Tailleux A, Bouly M, Luc G et al. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20(11), 2453\u20132458 (2000).","DOI":"10.1161\/01.ATV.20.11.2453"},{"key":"CIT0049","doi-asserted-by":"crossref","unstructured":"Remaley AT. Apolipoprotein A-II: still second fiddle in high-density lipoprotein metabolism? Arterioscler. Thromb. Vasc. Biol. 33(2), 166\u2013167 (2013).","DOI":"10.1161\/ATVBAHA.112.300921"},{"key":"CIT0050","doi-asserted-by":"crossref","unstructured":"Koike T, Kitajima S, Yu Y et al. Expression of human apoAII in transgenic rabbits leads to dyslipidemia: a new model for combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 29(12), 2047\u20132053 (2009).","DOI":"10.1161\/ATVBAHA.109.190264"},{"key":"CIT0051","doi-asserted-by":"crossref","unstructured":"Escola-Gil JC, Julve J, Marzal-Casacuberta A, Ordonez-Llanos J, Gonzalez-Sastre F, Blanco-Vaca F. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J. Lipid Res. 41(8), 1328\u20131338 (2000).","DOI":"10.1016\/S0022-2275(20)33441-6"},{"key":"CIT0052","doi-asserted-by":"crossref","unstructured":"Wang Y, Niimi M, Nishijima K et al. Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler. Thromb. Vasc. Biol. 33(2), 224\u2013231 (2013). \u25aa\u25aa According to this paper, transgenic expression of apoAII in rabbits, which do not naturally express apoAII, induces profound reduction in almost every measure of atherosclerosis.","DOI":"10.1161\/ATVBAHA.112.300445"},{"key":"CIT0053","unstructured":"Hedrick CC, Lusis AJ. Apolipoprotein A-II: a protein in search of a function. Can. J. Cardiol. 10(4), 453\u2013459 (1994)."},{"key":"CIT0054","doi-asserted-by":"crossref","unstructured":"Blanco-Vaca F, Escola-Gil JC, Martin-Campos JM, Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J. Lipid Res. 42(11), 1727\u20131739 (2001).","DOI":"10.1016\/S0022-2275(20)31499-1"},{"key":"CIT0055","doi-asserted-by":"crossref","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM et al. Effect of recombinant apoA-Imilano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290(17), 2292\u20132300 (2003).","DOI":"10.1001\/jama.290.17.2292"},{"key":"CIT0056","doi-asserted-by":"crossref","unstructured":"Nicholls SJ, Tuzcu EM, Sipahi I et al. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-Imilano. J. Am. Coll. Cardiol. 47(5), 992\u2013997 (2006).","DOI":"10.1016\/j.jacc.2005.11.040"},{"key":"CIT0057","doi-asserted-by":"crossref","unstructured":"Tardif JC, Gregoire J, L\u2019Allier PL et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA 297(15), 1675\u20131682 (2007).","DOI":"10.1001\/jama.297.15.jpc70004"},{"key":"CIT0058","doi-asserted-by":"crossref","unstructured":"Lackner KJ, Law SW, Brewer HB Jr. The human apolipoprotein A-II gene: complete nucleic acid sequence and genomic organization. Nucleic Acids Res. 13(12), 4597\u20134608 (1985).","DOI":"10.1093\/nar\/13.12.4597"},{"key":"CIT0059","doi-asserted-by":"crossref","unstructured":"Jackson RL, Gotto AM Jr, Lux SE, John KM, Fleischer S. Human plasma high density lipoprotein. Interaction of the cyanogen bromide fragments from apolipoprotein glutamine II (A-II) with phosphatidylcholine. J. Biol. Chem. 248(24), 8449\u20138456 (1973).","DOI":"10.1016\/S0021-9258(19)43154-2"},{"key":"CIT0060","doi-asserted-by":"crossref","unstructured":"Mao SJ, Sparrow JT, Gilliam EB, Gotto AM Jr, Jackson RL. Mechanism of lipid-protein interaction in the plasma lipoproteins: lipid-binding properties of synthetic fragments of apolipoprotein A-II. Biochemistry 16(19), 4150\u20134156 (1977).","DOI":"10.1021\/bi00638a003"},{"key":"CIT0061","doi-asserted-by":"crossref","unstructured":"Pownall HJ, Gotto AM Jr, Knapp RD, Massey JB. The helical hydrophobic moment avoids prolines in phospholipid-binding proteins. Biochem. Biophys. Res. Commun. 139(1), 202\u2013208 (1986).","DOI":"10.1016\/S0006-291X(86)80099-7"}],"container-title":["Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/clp.13.59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T19:18:39Z","timestamp":1644002319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/clp.13.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10,1]]}},"alternative-id":["10.2217\/clp.13.59"],"URL":"https:\/\/doi.org\/10.2217\/clp.13.59","relation":{},"ISSN":["1758-4299","1758-4302"],"issn-type":[{"value":"1758-4299","type":"print"},{"value":"1758-4302","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,1]]}}}